Overview
Wen Kong practices in Shanghai, China. Kong is highly rated in 4 conditions, according to our data. Their top areas of expertise are Renal Cell Carcinoma (RCC), Upper Tract Urothelial Carcinoma (UTUC), Fumarase Deficiency, Nephrectomy, and Thrombectomy.
Their clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Renal Cell Carcinoma (RCC)Kong isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Fumarase DeficiencyKong isAdvanced. Learn about Fumarase Deficiency.
- NephrectomyKong isAdvanced. Learn about Nephrectomy.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- Chromophobe Renal Cell Carcinoma
- EndoscopyKong isExperienced. Learn about Endoscopy.
- Lung MetastasesKong isExperienced. Learn about Lung Metastases.
- ThrombectomyKong isExperienced. Learn about Thrombectomy.
- Urothelial CancerKong isExperienced. Learn about Urothelial Cancer.